Clinical trial

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients…

NCT00209534 · Eisai Inc., Industry · Completed

Key facts

NCT number NCT00209534
Title A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Official title A Phase 2, Two Part Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Lead sponsor Eisai Inc., Industry
Collaborators Omnicare Clinical Research Industry Bio Analytical Research Corporation MDS Pharma Services The Coghlan Group (Plasma Sample Supplies) HHI Clinical Research (Biostatistics)
Status Completed
Phase Phase 2
Study type Interventional
Conditions Colonoscopy, Colon Polyps
Intervention type Drug
Interventions fospropofol disodium
Enrollment 200
Start date Jan 1, 2003
Completion Feb 1, 2004
First posted Sep 21, 2005
Last update posted Dec 4, 2009

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies